SI Group Announces Closing of Comprehensive Recapitalization, Positioning the Company for Accelerated Growth
Significant De-leveraging Transaction Resulting in Overall Debt Reduction of Approximately $1.7 Billion…
Clinical Data Demonstrating Efficacy of Sotagliflozin in Preserved Ejection Fraction Heart Failure (HFpEF) without Diabetes Presented at American Heart Association (AHA) Annual Scientific Sessions 2025
THE WOODLANDS, Texas, Nov. 08, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc.…
SI GROUP OPENS NEW INNOVATION CENTER
State-of-the-art facility expands company's global research and development capabilities THE WOODLANDS, Texas,…
SI GROUP BUILDS EMEA DISTRIBUTION NETWORK THROUGH NEW PARTNERSHIP WITH AZELIS
New collaboration will expand SI Group's customer reach complementing its long-standing partnership…